TABLE 1

Characteristics, 18F-FDG PET/CT Indications, Perihilar SUV, Histology, and Outcome of 20 Patients with Extrahepatic Bile Duct Strictures

Patient no.Age (y)SexIndication for 18F-FDG PET/CTPerihilar SUVmaxPerihilar SUV75%HistologyOutcome
163FStaging before surgery3.93.1CCCurative resection
246MStaging before surgery5.24.3CCCurative resection
368MStaging before surgery6.15.1CCCurative resection
466FStaging before surgery6.65.6CCCurative resection
571MStaging before PDT5.24.2CCStable disease
675MStaging before PDT6.35.2CCStable disease
776MStaging before PDT9.88.2CCStable disease
Tx control after PDT11.09.0CCDisease progress on CT 5 mo later
877FTx control after PDT15.811.8CCDisease progress on CT 6 mo later
976MTx control after PDT5.24.3CCStable disease for 6 mo
Follow-up after 6 mo7.15.9CCDisease progress on CT 7 mo later
1061FTx control after PDT3.93.2CCDisease progress on CT 9 mo later
1164FTx control after PDT5.04.1CCDisease progress on CT 14 mo later
1278FExclusion of CC*4.23.5CCCurative resection
1364MExclusion of CC*3.22.7No CC12-mo follow-up negative
1482FExclusion of CC*2.72.2No CC18-mo follow-up negative
1559MExclusion of CC*3.02.2No CC20-mo follow-up negative
1663MExclusion of CC*2.92.3No CC21-mo follow-up negative
1760MPSC, exclusion of CC*3.12.4No CC18-mo follow-up negative
1835FPSC, exclusion of CC*2.72.2No CC19-mo follow-up negative
1937FPSC, exclusion of CC*2.52.1No CC20-mo follow-up negative
2071FTx control after PDT of CC3.02.5No CC18-mo follow-up negative
  • * To avoid surgery when 18F-FDG PET/CT gave no evidence of malignancy.

  • CC = cholangiocarcinoma; Tx = therapy.